1 | 11C-acetate | [1] Acetic acid C-11 Acetic acid C-11 (11C-ACETATE) | - | - | - | [3] 13 13, 86, 88 💬
|
2 | 2% chlorhexidine solution wipes (Chlorhexidine acetate) | [1] Chlorhexidine Chlorhexidine (Chlorhexidine acetate) | [4] Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
(Chlorhexidine acetate) 💬
| - | - | [1] 299 299 💬
|
3 | 20MG/0.5ML glatiramer acetate | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
4 | 4% chlorhexidine gluconate liquid skin cleanser (Chlorhexidine acetate) | - | - | - | - | [1] 299 299 💬
|
5 | 40 MG glatiramer acetate | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [2] 2 2, 13 💬
|
6 | 40 MG glatiramer acetato (Glatiramer acetate, GLATIRAMER ACETATE) | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
7 | 90 MG hydrocortisone acetate suppository with sephure suppository applicator | [3] Acetate Acetate (Acetate), Hydrocortisone, Hydrocortisone acetate (Hydrocortisone 21-acetate) | [2] Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
(Hydrocortisone acetate) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
8 | Abiraterone acetate | [1] Abiraterone Abiraterone (Abiraterone acetate) | [1] Abiraterone acetate
Abiraterone acetate
(Abiraterone acetate, ABIRATERONE ACETATE) 💬
| [1] CYP17A CYP17A 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | [2] 75 75, 81 💬
|
9 | Abiraterone acetato (Abiraterone acetate, ABIRATERONE ACETATE) | [1] Abiraterone Abiraterone (Abiraterone acetate) | [1] Abiraterone acetate
Abiraterone acetate
(Abiraterone acetate, ABIRATERONE ACETATE) 💬
| [1] CYP17A CYP17A 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | [1] 75 75 💬
|
10 | Acetate | [1] Acetate Acetate (Acetate) | - | - | - | [14] 11 11, 46, 49, 51, 70, 71, 73, 76, 89, 97, 158, 235, 265, 299 💬
|
11 | Administration OF methylprednisolone + prednisone + mycophenolate mofetil (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 49 49 💬
|
12 | Administration OF methylprednisolone, paracetamol and dexchlorpheniramine (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 49 49 💬
|
13 | Administration OF rituximab and methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 51 51 💬
|
14 | Afamelanotide (Afamelanotide acetate) | [1] Afamelanotide Afamelanotide (Afamelanotide acetate) | [2] Afamelanotide
Afamelanotide
,
Afamelanotide acetate
(Afamelanotide acetate) 💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [2] 159 159, 254 💬
|
15 | Afamelanotide 16 MG (Afamelanotide acetate) | [1] Afamelanotide Afamelanotide (Afamelanotide acetate) | [2] Afamelanotide
Afamelanotide
,
Afamelanotide acetate
(Afamelanotide acetate) 💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 254 254 💬
|
16 | Afamelanotide 16MG implant (Afamelanotide acetate) | [1] Afamelanotide Afamelanotide (Afamelanotide acetate) | [2] Afamelanotide
Afamelanotide
,
Afamelanotide acetate
(Afamelanotide acetate) 💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 254 254 💬
|
17 | Afamelanotide implant (Afamelanotide acetate) | [1] Afamelanotide Afamelanotide (Afamelanotide acetate) | [2] Afamelanotide
Afamelanotide
,
Afamelanotide acetate
(Afamelanotide acetate) 💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 254 254 💬
|
18 | Angiotensin II (Angiotensin II acetate) | [1] Angiotensin II Angiotensin II (Angiotensin II acetate) | [3] Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
(Angiotensin II acetate) 💬
| [2] AGTR1 AGTR1, AGTR2 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 💬
|
19 | Atosiban (Atosiban acetate) | [1] Atosiban Atosiban (Atosiban acetate) | [2] Atosiban
Atosiban
,
Atosiban acetate
(Atosiban acetate) 💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 118 118 💬
|
20 | Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 296 296 💬
|
21 | Bazedoxifene acetate | [1] Bazedoxifene Bazedoxifene (Bazedoxifene acetate) | [1] Bazedoxifene acetate
Bazedoxifene acetate
(Bazedoxifene acetate) 💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 13 13 💬
|
22 | Betamethasone (Betamethasone acetate) | [1] Betamethasone Betamethasone (Betamethasone acetate) | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
(Betamethasone acetate),
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [5] 28 28, 83, 90, 96, 235 💬
|
23 | Betamethasone acibutate (Betamethasone acetate) | [1] Betamethasone Betamethasone (Betamethasone acetate) | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
(Betamethasone acetate),
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
24 | Betamethasone mouthwash (Betamethasone acetate) | [1] Betamethasone Betamethasone (Betamethasone acetate) | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
(Betamethasone acetate),
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 56 56 💬
|
25 | Betamethasone oral solution period 1 and period 2 (Betamethasone acetate) | [1] Betamethasone Betamethasone (Betamethasone acetate) | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
(Betamethasone acetate),
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
26 | Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 MG IM once A DAY FOR four days | [1] Betamethasone Betamethasone (Betamethasone acetate) | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
(Betamethasone acetate),
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 2 2 💬
|
27 | Betamethasone solution AS intramuscular injection period 1 and period 2 (Betamethasone acetate) | [1] Betamethasone Betamethasone (Betamethasone acetate) | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
(Betamethasone acetate),
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
28 | CAM2029 (octreotide subcutaneous depot) _prefilled syringe_prefilled syringe (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
29 | CAM2029 (octreotide subcutaneous depot)_ prefilled PEN (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
30 | CAM2029 (octreotide subcutaneous depot)_ prefilled syringe (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
31 | CAM2029 (octreotide subcutaneous depot)_pre-filled PEN (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
32 | CAM2029 (octreotide subcutaneous depot)_pre-filled syringe (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
33 | CAM2029 (octreotide subcutaneous depot)_prefilled PEN (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
34 | CAM2029 (octreotide subcutaneous depot)_prefilled syringe (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
35 | Caspofungin acetate | [1] Caspofungin Caspofungin (Caspofungin acetate) | [2] Caspofungin acetate
Caspofungin acetate
(Caspofungin acetate, CASPOFUNGIN ACETATE),
Caspofungin
💬
| - | - | [1] 60 60 💬
|
36 | Cellulose acetate with petrolatum | [1] Microcrystalline cellulose Microcrystalline cellulose | [2] Microcrystalline cellulose
Microcrystalline cellulose
,
Rayon, purified
💬
| - | - | [2] 35 35, 162 💬
|
37 | Cetrorelix (Cetrorelix acetate, CETRORELIX ACETATE) | [1] Cetrorelix Cetrorelix (Cetrorelix acetate) | [2] Cetrorelix acetate
Cetrorelix acetate
(Cetrorelix acetate, CETRORELIX ACETATE),
Cetrorelix
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
38 | Chlorhexidine (Chlorhexidine acetate) | [1] Chlorhexidine Chlorhexidine (Chlorhexidine acetate) | [4] Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
(Chlorhexidine acetate) 💬
| - | - | [1] 86 86 💬
|
39 | Chlorhexidine gluconate (Chlorhexidine acetate) | [1] Chlorhexidine Chlorhexidine (Chlorhexidine acetate) | [4] Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
(Chlorhexidine acetate) 💬
| - | - | [1] 299 299 💬
|
40 | Chlorhexidine gluconate oral rinse (Chlorhexidine acetate) | [1] Chlorhexidine Chlorhexidine (Chlorhexidine acetate) | [4] Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
(Chlorhexidine acetate) 💬
| - | - | [1] 299 299 💬
|
41 | Combination with somatostatin analogue octreotide (Octreotide acetate) | - | - | - | - | [1] 77 77 💬
|
42 | Cortisone acetate | [3] Cortisone Cortisone, Cortisone acetate (Cortisone acetate), Hydrocortisone | [3] Hydrocortisone
Hydrocortisone
,
Cortisone acetate
(Cortisone acetate, Cortone acetate),
Cortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
43 | Cosyntropin acetate | [1] Tetracosactide Tetracosactide (Tetracosactide acetate) | [2] Cosyntropin
Cosyntropin
,
Tetracosactide acetate
(Tetracosactide acetate) 💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 113 113 💬
|
44 | Cyclophosphamide, azathioprine,prednisone,methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 💬
|
45 | Cyclophosphamide/glatiramer acetate | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 13 13 💬
|
46 | Delmitide acetate | - | - | - | - | [1] 97 97 💬
|
47 | Depot leuprolide acetate 3.75 MG | - | - | - | - | [1] 51 51 💬
|
48 | Depot tetracosactide (Tetracosactide acetate) | - | - | - | - | [1] 83 83 💬
|
49 | Desmopressin (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) | [1] Desmopressin Desmopressin (Desmopressin acetate anhydrous) | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) 💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [3] 64 64, 75, 288 💬
|
50 | Desmopressin acetat (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) | [1] Desmopressin Desmopressin (Desmopressin acetate anhydrous) | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) 💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 6 6 💬
|
51 | Desmopressin acetate | [1] Desmopressin Desmopressin (Desmopressin acetate anhydrous) | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) 💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 288 💬
|
52 | Desmopressin acetate trihydrate | [1] Desmopressin Desmopressin (Desmopressin acetate anhydrous) | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) 💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 225 225 💬
|
53 | Desmopressin intranasal (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) | [1] Desmopressin Desmopressin (Desmopressin acetate anhydrous) | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) 💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 💬
|
54 | Desmopressin oral melt (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) | [1] Desmopressin Desmopressin (Desmopressin acetate anhydrous) | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate, DESMOPRESSIN ACETATE) 💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 💬
|
55 | Dirucotide acetate | [1] Dirucotide Dirucotide | [1] Dirucotide
Dirucotide
💬
| - | - | [1] 13 13 💬
|
56 | Edratide acetate | [1] Edratide Edratide | [1] Edratide
Edratide
💬
| - | - | [1] 49 49 💬
|
57 | Experimental glatiramer acetate | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
58 | Exposure TO methylprednisolone during pregnancy (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 13 13 💬
|
59 | Firazyr (icatibant) 30 MG solution FOR injection IN PRE filled syringe (Icatibant acetate) | [1] Icatibant Icatibant (Icatibant acetate) | [1] Icatibant acetate
Icatibant acetate
(Icatibant acetate) 💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
60 | Flecainide + BETA-blocker (Flecainide acetate) | [1] Flecainide Flecainide (Flecainide acetate) | [2] Flecainide acetate
Flecainide acetate
(Flecainide acetate),
Flecainide
💬
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 115 115 💬
|
61 | Flecainide acetate | [1] Flecainide Flecainide (Flecainide acetate) | [2] Flecainide acetate
Flecainide acetate
(Flecainide acetate),
Flecainide
💬
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 6 6 💬
|
62 | Fludrocortisone (Fludrocortisone acetate, Florinef acetate) | [1] Fludrocortisone Fludrocortisone (Fludrocortisone acetate) | [2] Fludrocortisone acetate
Fludrocortisone acetate
(Fludrocortisone acetate, Florinef acetate),
Fludrocortisone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [3] 6 6, 17, 81 💬
|
63 | Gallium-68-DOTA-N-octreotide (Octreotide acetate) | - | - | - | - | [1] 84 84 💬
|
64 | Glatiramer acetate | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [3] 13 13, 96, 156 💬
|
65 | Glatiramer acetate (GA) 40 MG | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
66 | Glatiramer acetate 150MG enteric coated tablets | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
67 | Glatiramer acetate 150MG enteric-coated (gastro-resistant) tablets | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
68 | Glatiramer acetate 20 MG | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
69 | Glatiramer acetate 20 MG, with mitoxantrone | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
70 | Glatiramer acetate 20 MG/0.5 ML | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
71 | Glatiramer acetate 40 MG | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
72 | Glatiramer acetate injection with oral cetirizine hydrochloride | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
73 | Glatiramer acetate with minocycline | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
74 | Glatiramer acetate, IFN-beta 1A (IM), IFN-beta 1A (subcutaneous), and IFN-beta 1B | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
75 | Glatiramer acetate, interferons (intramuscular, subcutaneous, pegylated) teriflunomide, fumarates (dimethyl, diroximel, monomethyl) fingolimod, siponimod, ozanimod, ponesimod | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
76 | Glatiramer acetate, N-acetylcysteine | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
77 | Glatiramer acetato (Glatiramer acetate, GLATIRAMER ACETATE) | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
78 | Gonadorelin acetate and triptorelin acetate | [2] Gonadorelin Gonadorelin (Gonadorelin acetate), Triptorelin (Triptorelin acetate) | [6] Gonadorelin hydrochloride
Gonadorelin hydrochloride
,
Gonadorelin acetate
(Gonadorelin acetate),
Triptorelin
,
Triptorelin pamoate
,
Gonadorelin
,
Triptorelin acetate
(Triptorelin acetate) 💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
79 | Goserelin (Goserelin acetate) | [1] Goserelin Goserelin (Goserelin acetate) | [2] Goserelin acetate
Goserelin acetate
(Goserelin acetate),
Goserelin
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 1 1 💬
|
80 | Guanabenz (Guanabenz acetate) | [1] Guanabenz Guanabenz (Guanabenz Acetate) | [2] Guanabenz acetate
Guanabenz acetate
(Guanabenz acetate),
Guanabenz
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
81 | Guanabenz acetato (Guanabenz acetate) | [1] Guanabenz Guanabenz (Guanabenz Acetate) | [2] Guanabenz acetate
Guanabenz acetate
(Guanabenz acetate),
Guanabenz
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 2 2 💬
|
82 | Hematide, peginesatide (Peginesatide acetate) | [1] Peginesatide Peginesatide (Peginesatide acetate) | [2] Peginesatide
Peginesatide
,
Peginesatide acetate
(Peginesatide acetate) 💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 283 283 💬
|
83 | HIGH-dose intravenous methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 13 13 💬
|
84 | Histrelin subcutaneous implant (Histrelin acetate) | [1] Histrelin Histrelin (Histrelin acetate) | [2] Histrelin acetate
Histrelin acetate
(Histrelin acetate),
Histrelin
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
85 | Human interferon BETA-1A and glatiramer acetate | [1] Human interferon beta Human interferon beta | [1] Interferon beta
Interferon beta
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
86 | Hydrocortisone sodium acetate | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
87 | Hydroxocobalamin with butyrate (Hydroxocobalamin acetate) | [2] Butyric Acid Butyric Acid, Hydroxocobalamin (Hydroxocobalamin acetate) | [3] Hydroxocobalamin
Hydroxocobalamin
,
Hydroxocobalamin acetate
(Hydroxocobalamin acetate),
Sodium butyrate
💬
| - | - | [1] 97 97 💬
|
88 | Icatibant (Icatibant acetate) | [1] Icatibant Icatibant (Icatibant acetate) | [1] Icatibant acetate
Icatibant acetate
(Icatibant acetate) 💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
89 | Icatibant acetate | [1] Icatibant Icatibant (Icatibant acetate) | [1] Icatibant acetate
Icatibant acetate
(Icatibant acetate) 💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
90 | Icatibant acetate solution FOR injection 10 MG/ML | [1] Icatibant Icatibant (Icatibant acetate) | [1] Icatibant acetate
Icatibant acetate
(Icatibant acetate) 💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
91 | Infliximab, methylprednisolone, methotrexate (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [2] Infliximab Infliximab, Methotrexate | [3] Methotrexate
Methotrexate
,
Methotrexate sodium
,
Infliximab
💬
| [3] DHFR DHFR, DHFR, TNF 💬
| [69] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
92 | Interferon or glatiramer acetate | - | - | - | - | [1] 13 13 💬
|
93 | Interferon-BETA-1A (avonex) plus methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [2] Human interferon beta Human interferon beta, Interferon beta-1a | [2] Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
94 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | - | - | - | - | [1] 13 13 💬
|
95 | Intra-articular compound betamethasone (Betamethasone acetate) | - | - | - | - | [1] 46 46 💬
|
96 | Intraarticular betamethasone (Betamethasone acetate) | - | - | - | - | [1] 46 46 💬
|
97 | Intravenous (I.V.) methylprednisolone 1000 MG, total 9 (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 222 222 💬
|
98 | Intravenous methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [2] 13 13, 97 💬
|
99 | Intravenous methylprednisolone (ivmp) and efgartigimod (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 13 13 💬
|
100 | IV methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 13 13 💬
|
101 | IV methylprednisolone administration (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
102 | L-lysyl-D-prolyl-L-threonine acetate | [1] Acetate Acetate (Acetate) | - | - | - | [1] 97 97 💬
|
103 | L-lysyl-D-prolyl-lthreonine acetate, lyophilisate | - | - | - | - | [1] 97 97 💬
|
104 | Lanreotide (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 67 67, 73, 77 💬
|
105 | Lanreotide (autogel formulation), duration OF treatment 24-56 weeks, depending ON dose interval (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
106 | Lanreotide (autogel formulation), duration OF treatment 46-48 weeks (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
107 | Lanreotide 60MG solution FOR injection (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
108 | Lanreotide acetate | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [4] 67 67, 77, 85, 298 💬
|
109 | Lanreotide acetato (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
110 | Lanreotide ATG (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
111 | Lanreotide ATG 120MG (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
112 | Lanreotide autogel (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
113 | Lanreotide autogel 120 MG (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
114 | Lanreotide autogel 120MG (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
115 | Lanreotide autogel and octreotide LAR (Octreotide acetate) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
116 | Lanreotide PRF (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
117 | Lanreotide-autogel 120 MG (Lanreotide acetate, LANREOTIDE ACETATE) | [1] Lanreotide Lanreotide (Lanreotide acetate) | [1] Lanreotide acetate
Lanreotide acetate
(Lanreotide acetate, LANREOTIDE ACETATE) 💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
118 | Lapaquistat acetate and current lipid-lowering treatment | [1] Lapaquistat Lapaquistat | - | - | - | [1] 79 79 💬
|
119 | Lefamulin (Lefamulin acetate) | [1] Lefamulin Lefamulin (Lefamulin acetate) | [2] Lefamulin
Lefamulin
,
Lefamulin acetate
(Lefamulin acetate) 💬
| - | - | [1] 299 299 💬
|
120 | Leuprolide (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE) | [1] Leuprolide Leuprolide (Leuprolide acetate) | [3] Leuprolide acetate
Leuprolide acetate
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE),
Leuprorelin
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [4] 1 1, 2, 3, 76 💬
|
121 | Leuprolide acetate 11.25 MG/ML | [1] Leuprolide Leuprolide (Leuprolide acetate) | [3] Leuprolide acetate
Leuprolide acetate
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE),
Leuprorelin
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
122 | Leuprolide acetate 3 month depot | [1] Leuprolide Leuprolide (Leuprolide acetate) | [3] Leuprolide acetate
Leuprolide acetate
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE),
Leuprorelin
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
123 | Leuprolide acetate 45 MG | [1] Leuprolide Leuprolide (Leuprolide acetate) | [3] Leuprolide acetate
Leuprolide acetate
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE),
Leuprorelin
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
124 | Leuprolide acetate depot | [1] Leuprolide Leuprolide (Leuprolide acetate) | [3] Leuprolide acetate
Leuprolide acetate
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE),
Leuprorelin
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
125 | Leuprolide mesylate, subcutaneous injection OF 42 MG leuprolide (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE) | [1] Leuprolide Leuprolide (Leuprolide acetate) | [3] Leuprolide acetate
Leuprolide acetate
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE),
Leuprorelin
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
126 | Leuprorelin acetate | [1] Leuprolide Leuprolide (Leuprolide acetate) | [3] Leuprolide acetate
Leuprolide acetate
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE),
Leuprorelin
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [2] 1 1, 76 💬
|
127 | Leuprorelin acetate 3.75MG injection | [1] Leuprolide Leuprolide (Leuprolide acetate) | [3] Leuprolide acetate
Leuprolide acetate
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE),
Leuprorelin
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
128 | Leuprorelin acetate depot 3M | [1] Leuprolide Leuprolide (Leuprolide acetate) | [3] Leuprolide acetate
Leuprolide acetate
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT, LEUPROLIDE ACETATE),
Leuprorelin
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
129 | Linaclotide (Linaclotide acetate) | [1] Linaclotide Linaclotide (Linaclotide acetate) | [2] Linaclotide acetate
Linaclotide acetate
(Linaclotide acetate),
Linaclotide
💬
| [1] GUCY2C GUCY2C 💬
| [2] Hormone signaling Hormone signaling, Purine metabolism 💬 | [2] 6 6, 97 💬
|
130 | Lysine (Lysine acetate, L-Lysine acetate) | [1] Lysine Lysine (Lysine acetate) | [4] Lysine acetate
Lysine acetate
(Lysine acetate, L-Lysine acetate),
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 228 228 💬
|
131 | Lysine-D-proline-threonine (Lysine acetate, L-Lysine acetate) | [1] Lysine Lysine (Lysine acetate) | [4] Lysine acetate
Lysine acetate
(Lysine acetate, L-Lysine acetate),
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 97 97 💬
|
132 | Megadose oral methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 13 13 💬
|
133 | Megestrol acetate tablet | [2] Megestrol Megestrol, Megestrol acetate (6-Methyl-17α-hydroxy-delta-progesterone acetate) | [2] Megestrol acetate
Megestrol acetate
(Megestrol acetate),
Megestrol
💬
| [1] PGR PGR 💬
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1] 76 76 💬
|
134 | Methotrexate + methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 46 46 💬
|
135 | Methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
136 | Methylprednisolone 1250 MG/24H X3 days (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
137 | Methylprednisolone acetate | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 51 💬
|
138 | Methylprednisolone and azathioprine (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 93 93, 95 💬
|
139 | Methylprednisolone and ivig (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
140 | Methylprednisolone and mycophenolate mofetil (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 93 93, 95 💬
|
141 | Methylprednisolone hemisuccinate (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [2] Methylprednisolone Methylprednisolone (Methylprednisolone acetate), Methylprednisolone hemisuccinate | [4] Methylprednisolone
Methylprednisolone
,
Methylprednisolone sodium succinate
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE),
Methylprednisolone hemisuccinate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 85 💬
|
142 | Methylprednisolone IV (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
143 | Methylprednisolone mylan GéNérique (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
144 | Methylprednisolone or budesonide (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
145 | Methylprednisolone or prednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
146 | Methylprednisolone PO (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
147 | Methylprednisolone pulse (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 220 💬
|
148 | Methylprednisolone sodium hemisuccinate (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 85, 97 💬
|
149 | Methylprednisolone sodium succinate (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [6] 13 13, 46, 49, 50, 51, 211 💬
|
150 | Methylprednisolone succinate (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [2] Methylprednisolone Methylprednisolone (Methylprednisolone acetate), Methylprednisolone hemisuccinate | [4] Methylprednisolone
Methylprednisolone
,
Methylprednisolone sodium succinate
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE),
Methylprednisolone hemisuccinate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 66 💬
|
151 | N''-[(E)-[(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-YL]PROP-2-EN-1-ylidene]amino]guanidinium acetate | - | - | - | - | [1] 46 46 💬
|
152 | Nomegestrol acetate | [2] Nomegestrol Nomegestrol, Nomegestrol acetate (Nomegestrol acetate) | [2] Nomegestrol
Nomegestrol
,
Nomegestrol acetate
(Nomegestrol acetate) 💬
| [1] PGR PGR 💬
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1] 13 13 💬
|
153 | Octreotide (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [8] 67 67, 75, 77, 84, 85, 89, 193, 227 💬
|
154 | Octreotide A azione pronta 0,1 MG (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 227 227 💬
|
155 | Octreotide acetate | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 77 77, 227 💬
|
156 | Octreotide acetate 30 MG suspension | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
157 | Octreotide acetate and cabergoline/octrotide and somavert | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
158 | Octreotide acetate microspheres FOR injection injection | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
159 | Octreotide acetate prolonged release, 30 MG | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
160 | Octreotide acetato (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 77 77, 227 💬
|
161 | Octreotide capsules (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
162 | Octreotide fluidcrystal® injection depot (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
163 | Octreotide hydrochloride (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
164 | Octreotide implant (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
165 | Octreotide LAR (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 67 67, 77, 227 💬
|
166 | Octreotide LAR 30 MG injection (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
167 | Octreotide LAR 30MG (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
168 | Octreotide-LAR (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 67 67, 77 💬
|
169 | Octreotide-LAR or lanreotide (Octreotide acetate) | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
170 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO methylprednisolone (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | - | - | - | - | [1] 97 97 💬
|
171 | Oral methylprednisolone 625 MG/24H X3 days (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Methylprednisolone Methylprednisolone (Methylprednisolone acetate) | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
(Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
172 | Peginesatide (Peginesatide acetate) | [1] Peginesatide Peginesatide (Peginesatide acetate) | [2] Peginesatide
Peginesatide
,
Peginesatide acetate
(Peginesatide acetate) 💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 283 283 💬
|
173 | Plovamer acetate | - | - | - | - | [1] 13 13 💬
|
174 | Plovamer acetate 10 MG | - | - | - | - | [1] 13 13 💬
|
175 | Plovamer acetate 20 MG | - | - | - | - | [1] 13 13 💬
|
176 | Plovamer acetate 3 MG | - | - | - | - | [1] 13 13 💬
|
177 | PRE-treatment with octreotide (Octreotide acetate) | - | - | - | - | [1] 77 77 💬
|
178 | Prednisolone acetate | [2] Prednisolone Prednisolone, Prednisolone acetate (Prednisolone acetate) | [2] Prednisolone
Prednisolone
,
Prednisolone acetate
(Prednisolone acetate, PREDNISOLONE ACETATE) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
179 | Prednisone acetate | [2] Prednisone Prednisone, Prednisone acetate (delta1-Cortisone-21-acetate) | [2] Prednisone
Prednisone
,
Prednisone acetate
(Prednisone acetate, Prednisone 21-acetate) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [6] 35 35, 46, 49, 63, 162, 222 💬
|
180 | Prednisone acetate tablets | [2] Prednisone Prednisone, Prednisone acetate (delta1-Cortisone-21-acetate) | [2] Prednisone
Prednisone
,
Prednisone acetate
(Prednisone acetate, Prednisone 21-acetate) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 40 40, 224 💬
|
181 | Prednisone, methylprednisolone,cyclophosphamides (Methylprednisolone acetate, METHYLPREDNISOLONE ACETATE) | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 💬
|
182 | Preoperative lanreotide treatment (Lanreotide acetate, LANREOTIDE ACETATE) | - | - | - | - | [1] 77 77 💬
|
183 | Sandostatin LAR ® (octreotide acetate LAR) 30 MG | [1] Octreotide Octreotide (Octreotide acetate) | [4] Octreotide
Octreotide
,
Octreotide acetate
(Octreotide acetate),
Octreotide pamoate
,
Octreotide acetate
(Octreotide acetate, OCTREOTIDE ACETATE) 💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
184 | Setmelanotide (Setmelanotide acetate) | [1] Setmelanotide Setmelanotide (Setmelanotide acetate) | [2] Setmelanotide
Setmelanotide
,
Setmelanotide acetate
(Setmelanotide acetate) 💬
| [1] MC4R MC4R 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [4] 134 134, 193, 202, 265 💬
|
185 | Sodium acetate | [1] Sodium acetate Sodium acetate (Sodium acetate) | [1] Sodium acetate
Sodium acetate
(Sodium acetate, Sodium acetate hydrate, Sodium acetate trihydrate, Sodium acetate, SODIUM ACETATE) 💬
| - | - | [1] 251 251 💬
|
186 | Sodium-[O-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate | - | - | - | - | [1] 46 46 💬
|
187 | Sodium-[O-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate | - | - | - | - | [1] 46 46 💬
|
188 | Sotrastaurin (INN) acetate | [1] Sotrastaurin Sotrastaurin (Sotrastaurin acetate) | [2] Sotrastaurin
Sotrastaurin
,
Sotrastaurin acetate
(Sotrastaurin acetate) 💬
| [4] PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬
| [29] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
189 | Teriparatide (Teriparatide acetate) | [1] Teriparatide Teriparatide (Teriparatide acetate) | [3] Teriparatide acetate
Teriparatide acetate
(Teriparatide acetate),
Teriparatide
,
Teriparatide acetate
(Teriparatide acetate, Teriparatide acetate hydrate) 💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [7] 46 46, 68, 70, 71, 172, 235, 274 💬
|
190 | Teriparatide conjugated TO A multiarm polyethylene glycol carrier molecule through A cleava (Teriparatide acetate) | [1] Teriparatide Teriparatide (Teriparatide acetate) | [3] Teriparatide acetate
Teriparatide acetate
(Teriparatide acetate),
Teriparatide
,
Teriparatide acetate
(Teriparatide acetate, Teriparatide acetate hydrate) 💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
191 | Teriparatide conjugated TO A multiarm polyethylene glycol carrier molecule through A cleavable linker (Teriparatide acetate) | [1] Teriparatide Teriparatide (Teriparatide acetate) | [3] Teriparatide acetate
Teriparatide acetate
(Teriparatide acetate),
Teriparatide
,
Teriparatide acetate
(Teriparatide acetate, Teriparatide acetate hydrate) 💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
192 | Teriparatide PEN injector (Teriparatide acetate) | [1] Teriparatide Teriparatide (Teriparatide acetate) | [3] Teriparatide acetate
Teriparatide acetate
(Teriparatide acetate),
Teriparatide
,
Teriparatide acetate
(Teriparatide acetate, Teriparatide acetate hydrate) 💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 274 274 💬
|
193 | Terlipressin acetate | [1] Terlipressin Terlipressin (Terlipressin acetate) | [2] Terlipressin
Terlipressin
,
Terlipressin acetate
(Terlipressin acetate) 💬
| [3] AVPR1A AVPR1A, AVPR1B, AVPR2 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | [1] 299 299 💬
|
194 | Tesamorelin (Tesamorelin acetate) | [1] Tesamorelin Tesamorelin (Tesamorelin acetate) | [2] Tesamorelin
Tesamorelin
,
Tesamorelin acetate
(Tesamorelin acetate) 💬
| [1] GHRHR GHRHR 💬
| [3] Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 265 265 💬
|
195 | Tetracosactide acetate | [1] Tetracosactide Tetracosactide (Tetracosactide acetate) | [2] Cosyntropin
Cosyntropin
,
Tetracosactide acetate
(Tetracosactide acetate) 💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 83 83, 145 💬
|
196 | Tetracosactide esacetato (Tetracosactide acetate) | [1] Tetracosactide Tetracosactide (Tetracosactide acetate) | [2] Cosyntropin
Cosyntropin
,
Tetracosactide acetate
(Tetracosactide acetate) 💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 113 113 💬
|
197 | Tetracosactide hexaacetate (Tetracosactide acetate) | [1] Tetracosactide Tetracosactide (Tetracosactide acetate) | [2] Cosyntropin
Cosyntropin
,
Tetracosactide acetate
(Tetracosactide acetate) 💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 113 113 💬
|
198 | Tetracosactide hexacetaat (Tetracosactide acetate) | [1] Tetracosactide Tetracosactide (Tetracosactide acetate) | [2] Cosyntropin
Cosyntropin
,
Tetracosactide acetate
(Tetracosactide acetate) 💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 222 222 💬
|
199 | Tocopherol acetate | [2] Tocopherol Tocopherol, alpha-Tocopherol acetate (Tocopherol acetate) | [2] Tocopherol acetate
Tocopherol acetate
(Tocopherol acetate),
Tocopherol
💬
| - | - | [1] 49 49 💬
|
200 | Tocopheryl acetate | [1] alpha-Tocopherol acetate alpha-Tocopherol acetate (Tocopherol acetate) | [1] Tocopherol acetate
Tocopherol acetate
(Tocopherol acetate) 💬
| - | - | [1] 206 206 💬
|
201 | Triptorelin (Triptorelin acetate) | [1] Triptorelin Triptorelin (Triptorelin acetate) | [3] Triptorelin
Triptorelin
,
Triptorelin pamoate
,
Triptorelin acetate
(Triptorelin acetate) 💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
202 | Triptorelin acetate and gonadorelin acetate | [2] Gonadorelin Gonadorelin (Gonadorelin acetate), Triptorelin (Triptorelin acetate) | [6] Gonadorelin hydrochloride
Gonadorelin hydrochloride
,
Gonadorelin acetate
(Gonadorelin acetate),
Triptorelin
,
Triptorelin pamoate
,
Gonadorelin
,
Triptorelin acetate
(Triptorelin acetate) 💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
203 | Triptorelin embonate, triptorelin pamoate (Triptorelin acetate) | [1] Triptorelin Triptorelin (Triptorelin acetate) | [3] Triptorelin
Triptorelin
,
Triptorelin pamoate
,
Triptorelin acetate
(Triptorelin acetate) 💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
204 | Triptorelin pamoate (Triptorelin acetate) | [1] Triptorelin Triptorelin (Triptorelin acetate) | [3] Triptorelin
Triptorelin
,
Triptorelin pamoate
,
Triptorelin acetate
(Triptorelin acetate) 💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [2] 49 49, 76 💬
|
205 | Triptorelin pamoate 15MG (Triptorelin acetate) | [1] Triptorelin Triptorelin (Triptorelin acetate) | [3] Triptorelin
Triptorelin
,
Triptorelin pamoate
,
Triptorelin acetate
(Triptorelin acetate) 💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
206 | Twice daily 90 MG hydrocortisone acetate suppository administered with sephure applicator | [3] Acetate Acetate (Acetate), Hydrocortisone, Hydrocortisone acetate (Hydrocortisone 21-acetate) | [2] Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
(Hydrocortisone acetate) 💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
207 | Ulipristal acetate | [1] Ulipristal Ulipristal (Ulipristal acetate) | [2] Ulipristal
Ulipristal
,
Ulipristal acetate
(Ulipristal acetate) 💬
| [1] PGR PGR 💬
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1] 10 10 💬
|
208 | Warm compress prior TO injection OF glatiramer acetate | [1] Glatiramer Glatiramer (Glatiramer acetate) | [1] Glatiramer acetate
Glatiramer acetate
(Glatiramer acetate, GLATIRAMER ACETATE) 💬
| [20] MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
209 | Zinc acetate | [2] Zinc Zinc, Zinc acetate (Zinc acetate dihydrate) | [1] Zinc acetate
Zinc acetate
(Zinc acetate, Zinc acetate hydrate, Zinc acetate dihydrate) 💬
| - | - | [2] 171 171, 299 💬
|
210 | Zinc acetate dihydrate | [1] Zinc acetate Zinc acetate (Zinc acetate dihydrate) | [1] Zinc acetate
Zinc acetate
(Zinc acetate, Zinc acetate hydrate, Zinc acetate dihydrate) 💬
| - | - | [1] 171 171 💬
|
211 | Zuretinol acetate | [1] Zuretinol acetate Zuretinol acetate (Zuretinol acetate) | - | - | - | [1] 90 90 💬
|